📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Antheia

1.1 - Company Overview

Antheia Logo

Antheia

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biosynthetic key starting materials (KSMs) and active pharmaceutical ingredients (APIs) for essential medicines using synthetic biology and engineered microbial fermentation, with a biomanufacturing platform enabling scalable, efficient, and sustainable commercial production while enhancing pharmaceutical supply chain resilience and rapid-response capabilities.

Products and services

  • Biosynthetic Active Pharmaceutical Ingredients (APIs) Production: Antheia produces biosynthetic APIs using fermentation-based microbes, boosting manufacturing efficiency and sustainability
  • Biosynthetic Key Starting Materials (KSMs) Production: Antheia fabricates synthetic-biology-driven KSMs for essential medicines through engineered microbial fermentation, enabling efficient and sustainable pharmaceutical manufacturing
  • Biomanufacturing Platform: Antheia architects a scalable synthetic biology platform that supports commercial manufacturing of pharmaceutical products, enhancing supply chain resilience and enabling rapid-response capabilities

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Antheia

TwinStrand Biosciences Logo

TwinStrand Biosciences

HQ: United States Website
  • Description: Provider of duplex sequencing technology for DNA sequencing.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full TwinStrand Biosciences company profile →
Brammer Bio Logo

Brammer Bio

HQ: United States Website
  • Description: Provider of CDMO services for cell and gene therapies, including viral vector process and analytical development, clinical and commercial manufacturing and fill-finish; full-service cell therapy cGMP manufacturing; translational research to standardize processes and analytics; and end-to-end mRNA development and manufacturing from plasmid production to cold-chain logistics.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Brammer Bio company profile →
Modis Therapeutics Logo

Modis Therapeutics

HQ: United States Website
  • Description: Provider of disease-modifying therapies to patients with rare genetic diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Modis Therapeutics company profile →
Caris Life Sciences Logo

Caris Life Sciences

HQ: United States Website
  • Description: Provider of molecular profiling and AI-driven precision oncology solutions, offering tissue-based profiling, specimen testing services to identify molecular cancer characteristics for personalized treatment, shipper kits for specimen transport, and billing services.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Caris Life Sciences company profile →
Lentigen Technology Logo

Lentigen Technology

HQ: United States Website
  • Description: Provider of gene delivery technologies and CDMO services for cell and gene therapy products, offering lentiviral vector technology for therapeutic, vaccine, and research applications; lentiviral vector design, evaluation, and scalable manufacturing; process development and clinical manufacturing; assay development via automated flow cytometry; and regulatory support from pre-IND to approval.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Lentigen Technology company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Antheia

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Antheia

2.2 - Growth funds investing in similar companies to Antheia

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Antheia

4.2 - Public trading comparable groups for Antheia

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Antheia

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Antheia

What does Antheia do?

Antheia is a provider of biosynthetic key starting materials (KSMs) and active pharmaceutical ingredients (APIs) for essential medicines using synthetic biology and engineered microbial fermentation, with a biomanufacturing platform enabling scalable, efficient, and sustainable commercial production while enhancing pharmaceutical supply chain resilience and rapid-response capabilities.

Who are Antheia's competitors?

Antheia's competitors and similar companies include TwinStrand Biosciences, Brammer Bio, Modis Therapeutics, Caris Life Sciences, and Lentigen Technology.

Where is Antheia headquartered?

Antheia is headquartered in United States.

How many employees does Antheia have?

Antheia has 1,000 employees 🔒.

When was Antheia founded?

Antheia was founded in 2010 🔒.

What sector and industry vertical is Antheia in?

Antheia is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Antheia

Who are the top strategic acquirers in Antheia's sector and industry

Top strategic M&A buyers and acquirers in Antheia's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Antheia?

Top strategic M&A buyers groups and sectors for Antheia include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Antheia's sector and industry vertical

Which are the top PE firms investing in Antheia's sector and industry vertical?

Top PE firms investing in Antheia's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Antheia's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Antheia's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Antheia's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Antheia include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Antheia's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Antheia?

The key public trading comparables and valuation benchmarks for Antheia include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Antheia for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Antheia with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Antheia's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Antheia with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Antheia's' sector and industry vertical?

Access recent funding rounds and capital raises in Antheia's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Antheia